Daiichi Sankyo Blood-Pressure Drug Gets European Union Approval
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo's Sevikar HCT for treating high blood pressure has gained approval in Germany, signaling its acceptance throughout the European Union